Sökresultat - "Screening"

A Novel 3D High-Throughput Phenotypic Drug Screening Pipeline to Identify Drugs with Repurposing Potential for the Treatment of Ovarian Cancer.

Karimnia N; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC, 3168, Australia.; Department of Molecular and Translational Sciences, Monash University, 45 Kanooka Grove, Clayton, VIC, 3168, Australia., Wilson AL; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC, 3168, Australia.; Department of Molecular and Translational Sciences, Monash University, 45 Kanooka Grove, Clayton, VIC, 3168, Australia., Doran BR; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC, 3168, Australia.; Department of Molecular and Translational Sciences, Monash University, 45 Kanooka Grove, Clayton, VIC, 3168, Australia., Do J; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC, 3168, Australia.; Department of Molecular and Translational Sciences, Monash University, 45 Kanooka Grove, Clayton, VIC, 3168, Australia., Matthews A; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC, 3168, Australia.; Department of Molecular and Translational Sciences, Monash University, 45 Kanooka Grove, Clayton, VIC, 3168, Australia., Ho GY; School of Clinical Sciences, Monash University, 27 Rainforest Walk, Clayton, VIC, 3168, Australia.; Department of Oncology, Monash Health, 823-865 Centre Rd, Bentleigh, VIC, 3165, Australia., Plebanski M; School of Health and Biomedical Sciences, RMIT University, Bundoora campus West, 203, 1/2 Plenty Rd, Bundoora, VIC, 3083, Australia., Jobling TW; Monash Medical Centre, Department of Gynecology Oncology, Monash Health, 823-865 Centre Rd, Bentleigh East, VIC, 3165, Australia., Stephens AN; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC, 3168, Australia.; Department of Molecular and Translational Sciences, Monash University, 45 Kanooka Grove, Clayton, VIC, 3168, Australia., Bilandzic M; Hudson Institute of Medical Research, 27-31 Wright St, Clayton, VIC, 3168, Australia.; Department of Molecular and Translational Sciences, Monash University, 45 Kanooka Grove, Clayton, VIC, 3168, Australia.

Journal Article , 2025

High-Throughput Chemotherapeutic Drug Screening System for Gastric Cancer (Cure-GA).

Lee J; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Kim IH; Department of Precision Medicine, Medical and Bio Decision (MBD Co., Ltd), Suwon, Republic of Korea., Seol D; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Lee S; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.; Department of Surgery, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea., Yoo M; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Lee TK; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Yoon SH; Department of Precision Medicine, Medical and Bio Decision (MBD Co., Ltd), Suwon, Republic of Korea., Lee E; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.; Department of Surgery, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Republic of Korea., Hwang D; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Kang SH; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Park YS; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Ku B; Department of Precision Medicine, Medical and Bio Decision (MBD Co., Ltd), Suwon, Republic of Korea., Jeon SY; Department of Precision Medicine, Medical and Bio Decision (MBD Co., Ltd), Suwon, Republic of Korea., Choi Y; Department of Precision Medicine, Medical and Bio Decision (MBD Co., Ltd), Suwon, Republic of Korea., Jung K; Department of Anatomy and Cell Biology / Biomedical Sciences, Seoul National University College of Medicine, Seoul, Republic of Korea., Kim JW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Kim JW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Ahn SH; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea., Kim HH; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.; Department of Surgery, Chung-Ang University Gwangmyeong Hospital, Gwangmyeong, Republic of Korea., Oh HJ; Department of Pathology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. biohjoh212@gmail.com., Lee DW; Department of Biomedical Engineering, Gachon University, Seongnam, Republic of Korea. dw2010.lee@gmail.com., Suh YS; Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea. ysksuh@snubh.org.; Department of Surgery, Seoul National University College of Medicine, Seoul, Republic of Korea. ysksuh@snubh.org.

Journal Article , 2025

Protocol to identify small-molecule inhibitors against cancer drug resistance.

Wei J; School of Science, Tianjin University, Tianjin, China., Zhang SY; School of Life Sciences, Tianjin University, Tianjin, China., Zhou XY; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China., Wei Y; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China., Jia HR; Institute of Molecular Medicine (IMM), Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: jiahr@ucas.ac.cn., Wu Q; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China. Electronic address: wuqin@ibmc.ac.cn., Tan W; Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China; Institute of Molecular Medicine (IMM), Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address: tan@hnu.edu.cn.

Journal Article , 2025

High-Throughput Programmable Tumor Spheroid Generation Using the Magneto-Archimedes Effect.

Zhang X; State Key Laboratory of Urban Water Resource and Environment, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, 92 West Da-Zhi Street, Harbin 150001, China., Li C; State Key Laboratory of Urban Water Resource and Environment, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, 92 West Da-Zhi Street, Harbin 150001, China., Li S; State Key Laboratory of Urban Water Resource and Environment, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, 92 West Da-Zhi Street, Harbin 150001, China., Tang X; State Key Laboratory of Urban Water Resource and Environment, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, 92 West Da-Zhi Street, Harbin 150001, China., Zhao J; State Key Laboratory of Urban Water Resource and Environment, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, 92 West Da-Zhi Street, Harbin 150001, China., Xu W; State Key Laboratory of Urban Water Resource and Environment, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, 92 West Da-Zhi Street, Harbin 150001, China., Han X; State Key Laboratory of Urban Water Resource and Environment, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, 92 West Da-Zhi Street, Harbin 150001, China.

Journal Article , 2025

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine.

Langenberg KPS; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: k.p.s.langenberg@prinsesmaximacentrum.nl., van Hooff SR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: s.r.vanhooff-3@prinsesmaximacentrum.nl., Koopmans B; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: B.Koopmans@prinsesmaximacentrum.nl., Strijker JGM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: J.G.M.Strijker@prinsesmaximacentrum.nl., Kholosy WM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: w.kholosy@amsterdamumc.nl., Ober K; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: k.ober@erasmusmc.nl., Zwijnenburg DA; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, the Netherlands. Electronic address: dannyzwijnenburg@amsterdamumc.nl., van der Hoek JJF; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands., Keller KM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: k.keller@nki.nl., Vernooij L; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands., Schild LG; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: g.g.schild@prinsesmaximacentrum.nl., Looze EJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: E.J.Looze@prinsesmaximacentrum.nl., Ebus ME; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands., Essing AHW; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands., Vree P; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands., Tas ML; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands., Matser YAH; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: Y.A.H.Matser@prinsesmaximacentrum.nl., Wienke J; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: J.Wienke-4@prinsesmaximacentrum.nl., Volckmann R; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, the Netherlands. Electronic address: r.volckmann@amsterdamumc.nl., Tops BBJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: b.b.j.tops@prinsesmaximacentrum.nl., Kester LA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: L.A.Kester@prinsesmaximacentrum.nl., Badloe S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: S.Badloe@prinsesmaximacentrum.nl., Hehir-Kwa JY; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: J.Y.HehirKwa@prinsesmaximacentrum.nl., Kemmeren P; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; Center for Molecular Medicine, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands. Electronic address: p.kemmeren@prinsesmaximacentrum.nl., Goemans BF; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: b.f.goemans@prinsesmaximacentrum.nl., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: c.m.zwaan@prinsesmaximacentrum.nl., Oehme I; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, Heidelberg 69120 , the Netherlands; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Im Neuenheimer Feld 430, Heidelberg 69120, Germany. Electronic address: i.oehme@kitz-heidelberg.de., Jäger N; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, Heidelberg 69120 , the Netherlands. Electronic address: n.jaeger@kitz-heidelberg.de., Witt O; Hopp Children's Cancer Center Heidelberg (KiTZ), German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, Heidelberg 69120 , the Netherlands; Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ), and German Cancer Consortium (DKTK), Im Neuenheimer Feld 430, Heidelberg 69120, Germany; Department of Pediatric Oncology, Hematology, Immunology and Pulmonology, Heidelberg University Hospital,National Center for Tumor Diseases (NCT) Network, Heidelberg, Germany. Electronic address: o.witt@kitz-heidelberg.de., van Eijkelenburg NKA; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: n.k.a.vaneijkelenburg@prinsesmaximacentrum.nl., Dierselhuis MP; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: m.p.dierselhuis@prinsesmaximacentrum.nl., Tytgat GAM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: G.A.M.Tytgat@prinsesmaximacentrum.nl., Wijnen MHW; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: m.h.w.wijnen-5@prinsesmaximacentrum.nl., van Noesel MM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; Division Imaging & Cancer, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands. Electronic address: m.m.vannoesel@prinsesmaximacentrum.nl., de Krijger RR; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands. Electronic address: r.r.dekrijger-2@prinsesmaximacentrum.nl., Eising S; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: selma.eising@xilis.nl., Koster J; Department of Oncogenomics, Cancer Center Amsterdam, Amsterdam UMC, the Netherlands. Electronic address: jankoster@amsterdamumc.nl., Dolman EM; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands. Electronic address: edolman@ccia.org.au., Molenaar JJ; Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, Utrecht 3584 CS, the Netherlands; Department of Pharmaceutical Sciences, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, the Netherlands. Electronic address: j.j.molenaar@prinsesmaximacentrum.nl.

Journal Article , 2025

Ultradense Electrochemical Chip and Machine Learning for High-Throughput, Accurate Anticancer Drug Screening.

Doretto DS; Brazilian Nanotechnology National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo 13083-970, Brazil.; Institute of Chemistry, University of Campinas, Campinas, São Paulo 13083-970, Brazil., Corsato PCR; Institute of Chemistry, University of Campinas, Campinas, São Paulo 13083-970, Brazil., Silva CO; Brazilian Nanotechnology National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo 13083-970, Brazil.; Department of Chemistry, Federal University of São Carlos, Sao Carlos, São Paulo 13565-905, Brazil., Pessoa JC; Brazilian Nanotechnology National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo 13083-970, Brazil.; Institute of Chemistry, University of Campinas, Campinas, São Paulo 13083-970, Brazil., Vieira LCS; Brazilian Nanotechnology National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo 13083-970, Brazil., de Araújo WR; Institute of Chemistry, University of Campinas, Campinas, São Paulo 13083-970, Brazil., Shimizu FM; Brazilian Nanotechnology National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo 13083-970, Brazil., O Piazzetta MH; Brazilian Nanotechnology National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo 13083-970, Brazil., Gobbi AL; Brazilian Nanotechnology National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo 13083-970, Brazil., S Ribeiro IR; Brazilian Synchrotron Light Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo 13083-970, Brazil., Lima RS; Brazilian Nanotechnology National Laboratory, Brazilian Center for Research in Energy and Materials, Campinas, São Paulo 13083-970, Brazil.; Institute of Chemistry, University of Campinas, Campinas, São Paulo 13083-970, Brazil.; Center for Natural and Human Sciences, Federal University of ABC, Santo Andre, São Paulo 09210-580, Brazil.; São Carlos Institute of Chemistry, University of São Paulo, Sao Carlos, São Paulo 13565-590, Brazil.

Journal Article; Research Support, Non-U.S. Gov't , 2025

High-Throughput Empirical and Virtual Screening To Discover Novel Inhibitors of Polyploid Giant Cancer Cells in Breast Cancer.

Ma Y; UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States.; Department of Computational and Systems Biology, University of Pittsburgh, 3420 Forbes Avenue, Pittsburgh, Pennsylvania 15260, United States., Shih CH; UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States., Cheng J; UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States.; Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, 3700 O'Hara Street, Pittsburgh, Pennsylvania 15260, United States., Chen HC; UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States.; Department of Computational and Systems Biology, University of Pittsburgh, 3420 Forbes Avenue, Pittsburgh, Pennsylvania 15260, United States., Wang LJ; UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States., Tan Y; UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States.; Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh, 5150 Centre Avenue, Pittsburgh, Pennsylvania 15232, United States., Zhang Y; UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States.; Department of Immunology, University of Pittsburgh, 5051 Centre Ave, Pittsburgh, Pennsylvania 15213, United States., Brown DD; Institute for Precision Medicine, University of Pittsburgh, 5051 Centre Ave, Pittsburgh, Pennsylvania 15213, United States., Oesterreich S; UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States.; Department of Pharmacology and Chemical Biology, University of Pittsburgh, 4200 Fifth Avenue, Pittsburgh, Pennsylvania 15213, United States., Lee AV; UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States.; Institute for Precision Medicine, University of Pittsburgh, 5051 Centre Ave, Pittsburgh, Pennsylvania 15213, United States.; Department of Pharmacology and Chemical Biology, University of Pittsburgh, 4200 Fifth Avenue, Pittsburgh, Pennsylvania 15213, United States., Chiu YC; UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States.; Department of Computational and Systems Biology, University of Pittsburgh, 3420 Forbes Avenue, Pittsburgh, Pennsylvania 15260, United States.; Division of Malignant Hematology and Medical Oncology, Department of Medicine, University of Pittsburgh, 5150 Centre Avenue, Pittsburgh, Pennsylvania 15232, United States.; CMU-Pitt Ph.D. Program in Computational Biology, University of Pittsburgh, 3420 Forbes Avenue, Pittsburgh, Pennsylvania 15260, United States., Chen YC; UPMC Hillman Cancer Center, University of Pittsburgh, 5115 Centre Ave, Pittsburgh, Pennsylvania 15232, United States.; Department of Computational and Systems Biology, University of Pittsburgh, 3420 Forbes Avenue, Pittsburgh, Pennsylvania 15260, United States.; Department of Bioengineering, Swanson School of Engineering, University of Pittsburgh, 3700 O'Hara Street, Pittsburgh, Pennsylvania 15260, United States.; CMU-Pitt Ph.D. Program in Computational Biology, University of Pittsburgh, 3420 Forbes Avenue, Pittsburgh, Pennsylvania 15260, United States.

Journal Article , 2025

Identification of C/EBPδ-Modifying Compounds as Potential Anticancer Agents Using a High-Throughput Drug Screen.

Hartl L; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Duitman J; Department of Pulmonary Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Department of Experimental Immunology, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Inflammatory Diseases, Amsterdam Infection & Immunity, Amsterdam, The Netherlands., Aberson HL; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Medema JP; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Bijlsma MF; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands., Spek CA; Laboratory for Experimental Oncology and Radiobiology, Center for Experimental and Molecular Medicine, Amsterdam UMC Location University of Amsterdam, Amsterdam, The Netherlands.; Cancer Biology and Immunology, Cancer Center Amsterdam, Amsterdam, The Netherlands.

Journal Article , 2025

High-throughput solutions in tumor organoids: from culture to drug screening.

Zuo J; The Key Laboratory of Biomarker High Throughput Screening and Target Translation of Breast and Gastrointestinal Tumor, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Zhongshan, Dalian 116001, Liaoning, China., Fang Y; The Key Laboratory of Biomarker High Throughput Screening and Target Translation of Breast and Gastrointestinal Tumor, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Zhongshan, Dalian 116001, Liaoning, China.; Liaoning Key Laboratory of Molecular Recognition and Imaging, School of Bioengineering, Dalian University of Technology, Dalian 116024, China., Wang R; The Key Laboratory of Biomarker High Throughput Screening and Target Translation of Breast and Gastrointestinal Tumor, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Zhongshan, Dalian 116001, Liaoning, China., Liang S; The Key Laboratory of Biomarker High Throughput Screening and Target Translation of Breast and Gastrointestinal Tumor, Affiliated Zhongshan Hospital of Dalian University, No. 6 Jiefang Street, Zhongshan, Dalian 116001, Liaoning, China.

Journal Article; Review , 2025

High-Throughput Drug Screening in Chondrosarcoma Cells Identifies Effective Antineoplastic Agents Independent of IDH Mutation.

Li L; Department of Medicine, Division of Medical Oncology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL 33136, USA., Hashemi L; College of Science, Northeastern University, Boston, MA 02115, USA., Eid J; Department of Medicine, Division of Medical Oncology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL 33136, USA., Tao W; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL 33136, USA.; Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL 33136, USA., Campoverde L; The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yu A; Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA., Farooqi AA; Institute of Biomedical and Genetic Engineering, Islamabad 44000, Pakistan., Al-Ali H; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL 33136, USA.; Department of Neurosurgery, University of Miami Miller School of Medicine, Miami, FL 33136, USA.; Miami Project to Cure Paralysis, University of Miami Miller School of Medicine, Miami, FL 33136, USA.; Katz Family Division of Nephrology and Hypertension, Department of Medicine, University of Miami Miller School of Medicine, Miami, FL 33136, USA.; Peggy and Harold Katz Family Drug Discovery Center, University of Miami Miller School of Medicine, Miami, FL 33136, USA.; Frost Institute for Data Science and Computing, University of Miami Miller School of Medicine, Miami, FL 33136, USA., D'Amato G; Department of Medicine, Division of Medical Oncology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL 33136, USA., Hornicek F; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL 33136, USA.; Department of Orthopedics, University of Miami Miller School of Medicine, Miami, FL 33136, USA., Duan Z; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL 33136, USA.; Department of Orthopedics, University of Miami Miller School of Medicine, Miami, FL 33136, USA., Lohse I; Center for Therapeutic Innovation, University of Miami Miller School of Medicine, Miami, FL 33136, USA.; Department of Orthopedic Surgery, University of Pittsburgh, Pittsburgh, PA 15213, USA., Trent J; Department of Medicine, Division of Medical Oncology, University of Miami Miller School of Medicine, Miami, FL 33136, USA.; Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, FL 33136, USA.

Journal Article , 2024

Protocol for the Australian Type 1 Diabetes National Screening Pilot: Assessing the feasibility and acceptability of three general population screening models in children.

Bell KJ; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Brodie S; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Couper JJ; Diabetes and Endocrinology, Women's and Children's Hospital, Adelaide, South Australia, Australia.; Robinson Research Institute, University of Adelaide, Adelaide, South Australia, Australia., Colman P; Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Parkville, Victoria, Australia.; Royal Melbourne Hospital, University of Melbourne Department of Medicine, Parkville, Victoria, Australia., Davis E; Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Nedlands, Western Australia, Australia.; Department of Endocrinology and Diabetes, Perth Children's Hospital, Nedlands, Western Australia, Australia., Deed G; Monash University, Melbourne, Victoria, Australia., Hagopian W; University of Washington, Seattle, Washington, USA.; Indiana University, Indianapolis, Indiana, USA., Haynes A; Children's Diabetes Centre, Telethon Kids Institute, The University of Western Australia, Nedlands, Western Australia, Australia.; UWA Medical School, Paediatrics, the University of Western Australia, Nedlands, Western Australia, Australia., Hendrieckx C; School of Psychology, Deakin University, Geelong, Victoria, Australia.; Institute for Health Transformation, Deakin University, Geelong, Victoria, Australia.; The Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, Victoria, Australia., Henry A; Discipline of Women's Health, School of Clinical Medicine, UNSW Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia., Gordon A; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Sydney Institute for Women, Children and Families, Sydney Local Health District, Camperdown, New South Wales, Australia., Howard K; Menzies Centre for Health Policy and Economics, School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Huynh T; Department of Endocrinology and Diabetes, Queensland Children's Hospital, South Brisbane, Queensland, Australia.; Children's Health Research Centre, Faculty of Medicine, The University of Queensland, South Brisbane, Queensland, Australia.; Department of Chemical Pathology, Mater Pathology, South Brisbane, Queensland, Australia., Kerr B; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Mikler K; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Nassar N; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Child Population and Translational Health Research, Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Norris S; Menzies Centre for Health Policy and Economics, School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Oram R; University of Exeter College of Medicine and Health, Exeter, UK.; Royal Devon University Healthcare NHS Foundation Trust, Exeter, UK., Pawlak D; JDRF Australia, Sydney, New South Wales, Australia., Shand A; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Royal Hospital for Women, Randwick, New South Wales, Australia., Sinnott RO; School of Computing and Information Systems, The University of Melbourne, Melbourne, Victoria, Australia., Wadling B; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Wentworth JM; Department of Diabetes and Endocrinology, Royal Melbourne Hospital, Parkville, Victoria, Australia.; Royal Melbourne Hospital, University of Melbourne Department of Medicine, Parkville, Victoria, Australia.; Population Health and Immunity Division, Walter and Eliza Hall Institute, Parkville, Victoria, Australia., Craig ME; Charles Perkins Centre, The University of Sydney, Sydney, New South Wales, Australia.; Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.; Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.; Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Medicine and Health, University of New South Wales, Sydney, New South Wales, Australia.

Type 1 Diabetes National Screening Pilot Study Group

Journal Article , 2024

High-throughput formulation of reproducible 3D cancer microenvironments for drug testing in myeloid leukemia.

Rudzinska-Radecka M; Institute of Physical Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52, 01-224 Warsaw, Poland.; Equal contribution.v., Turos-Korgul L; Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Str., Warsaw 02-093, Poland.; Equal contribution.v., Mukherjee D; Institute of Physical Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52, 01-224 Warsaw, Poland., Podszywalow-Bartnicka P; Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Str., Warsaw 02-093, Poland., Piwocka K; Laboratory of Cytometry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur Str., Warsaw 02-093, Poland., Guzowski J; Institute of Physical Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44/52, 01-224 Warsaw, Poland.

Journal Article , 2024

Patient-Derived Melanoma Immune-Tumoroids as a Platform for Precise High throughput Drug Screening.

Viegas J; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal., Costa S; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal., Dias S; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal.; INEB-Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal., Pereira CL; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal.; INEB-Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal., Sarmento B; i3S-Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal.; INEB-Instituto de Engenharia Biomédica, Universidade do Porto, Rua Alfredo Allen 208, Porto, 4200-135, Portugal.; IUCS-CESPU-Instituto Universitário de Ciências da Saúde, Rua Central de Gandra 1317, Gandra, 4585-116, Portugal.

Journal Article , 2024

A Screening Strategy to Mitigate Vision Impairment by Engaging Adults Who Underuse Eye Care Services.

Sherman E; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor., Niziol LM; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor., Hicks PM; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor., Johnson-Griggs M; University of Michigan Medical School, Ann Arbor., Elam AR; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor., Woodward MA; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor., Bicket AK; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor., Wood SD; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor., John D; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor., Johnson L; Hamilton Community Health Network, Flint, Michigan., Kershaw M; Hope Clinic, Ypsilanti, Michigan., Zhang J; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor., Zhang A; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor., Musch DC; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.; Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor., Newman-Casey PA; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor.; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor.

Journal Article; Multicenter Study; Comment , 2024

Pneumatic extrusion bioprinting-based high throughput fabrication of a melanoma 3D cell culture model for anti-cancer drug screening.

de Villiers M; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences North-West University, Private Bag X6001, Potchefstroom 2520, South Africa., Kotzé AF; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences North-West University, Private Bag X6001, Potchefstroom 2520, South Africa., du Plessis LH; Centre of Excellence for Pharmaceutical Sciences, Faculty of Health Sciences North-West University, Private Bag X6001, Potchefstroom 2520, South Africa.

Journal Article , 2024

Automated Uniform Spheroid Generation Platform for High Throughput Drug Screening Process.

Pong KCC; Department of Biomedical Engineering, The Chinese University of Hong Kong, New Territories, Hong Kong, China.; BioArchitec Group Limited, Hong Kong, China., Lai YS; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China., Wong RCH; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China., Lee ACK; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China., Chow SCT; BioArchitec Group Limited, Hong Kong, China., Lam JCW; BioArchitec Group Limited, Hong Kong, China., Ho HP; Department of Biomedical Engineering, The Chinese University of Hong Kong, New Territories, Hong Kong, China., Wong CTT; State Key Laboratory of Chemical Biology and Drug Discovery, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong, China.

Journal Article , 2024

In vitro throughput screening of anticancer drugs using patient-derived cell lines cultured on vascularized three-dimensional stromal tissues.

Takahashi Y; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan; Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan., Morimura R; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan; Division of Clinical Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan., Tsukamoto K; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan., Gomi S; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan., Yamada A; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan; Joint Research Laboratory (TOPPAN) for Advanced Cell Regulatory Chemistry, Graduate School of Engineering, Osaka University, Osaka 565-0871, Japan., Mizukami M; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan., Naito Y; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan; Joint Research Laboratory (TOPPAN) for Advanced Cell Regulatory Chemistry, Graduate School of Engineering, Osaka University, Osaka 565-0871, Japan., Irie S; Joint Research Laboratory (TOPPAN) for Advanced Cell Regulatory Chemistry, Graduate School of Engineering, Osaka University, Osaka 565-0871, Japan., Nagayama S; Department of Colorectal Surgery, Gastroenterological Cancer Center, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan; Department of Surgery, Uji Tokushukai Medical Center, Kyoto 611-0041, Japan., Shinozaki E; Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan., Yamaguchi K; Department of Gastroenterological Chemotherapy, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan., Fujita N; Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan., Kitano S; Business Development Division, Technical Research Institute, TOPPAN Holdings Inc., Saitama 345-8508, Japan; Joint Research Laboratory (TOPPAN) for Advanced Cell Regulatory Chemistry, Graduate School of Engineering, Osaka University, Osaka 565-0871, Japan. Electronic address: shiro.kitano@toppan.co.jp., Katayama R; Division of Experimental Chemotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo 135-8550, Japan. Electronic address: ryohei.katayama@jfcr.or.jp., Matsusaki M; Joint Research Laboratory (TOPPAN) for Advanced Cell Regulatory Chemistry, Graduate School of Engineering, Osaka University, Osaka 565-0871, Japan; Department of Applied Chemistry Graduate School of Engineering Osaka University, Osaka 565-0871, Japan. Electronic address: m-matsusaki@chem.eng.osaka-u.ac.jp.

Journal Article; Research Support, Non-U.S. Gov't , 2024

High-throughput drug screening identifies novel therapeutics for Low Grade Serous Ovarian Carcinoma.

Pishas KI; Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3010, Australia., Cowley KJ; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia., Llaurado-Fernandez M; Division of Gynecology Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, V5Z 1M9, Canada.; Department of Clinical Research, BC Cancer, Vancouver, British Columbia, V5Z 4E6, Canada., Kim H; Division of Gynecology Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, V5Z 1M9, Canada.; Department of Clinical Research, BC Cancer, Vancouver, British Columbia, V5Z 4E6, Canada., Luu J; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia., Vary R; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia., Bowden NA; School of Medicine and Public Health, University of Newcastle, Callaghan, New South Wales, Australia.; Drug Repurposing and Medicines Research Program, Hunter Medical Research Institute, New Lambton, New South Wales, 2305, Australia., Campbell IG; Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3010, Australia., Carey MS; Division of Gynecology Oncology, Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, V5Z 1M9, Canada.; Department of Clinical Research, BC Cancer, Vancouver, British Columbia, V5Z 4E6, Canada., Simpson KJ; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3010, Australia. kaylene.simpson@petermac.org.; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia. kaylene.simpson@petermac.org.; Department of Biochemistry and Pharmacology, The University of Melbourne, Parkville, Victoria, 3010, Australia. kaylene.simpson@petermac.org., Cheasley D; Peter MacCallum Cancer Centre, Melbourne, Victoria, 3000, Australia.; The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Victoria, 3010, Australia.

Journal Article; Dataset , 2024

High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in sonic hedgehog-medulloblastoma.

Zhou L; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., van Bree N; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Boutin L; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Ryu J; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Moussaud S; Chemical Biology Consortium Sweden (CBCS), Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Liu M; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden., Otrocka M; Chemical Biology Consortium Sweden (CBCS), Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden., Olsson M; Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm, Sweden., Falk A; Department of Experimental Medical Science, Lund Stem Cell Center, Lund University, Lund, Sweden.; Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden., Wilhelm M; Department of Microbiology, Tumor, and Cell Biology (MTC), Karolinska Institutet, Stockholm, Sweden.

Journal Article , 2024

Universal eye screening: perinatal risk factors and ocular abnormalities in 1795 newborns not meeting retinopathy of prematurity criteria.

Nayak S; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Kode Venkatadri Chowdary Campus), Vijayawada, Andhra Pradesh, India.; David Brown Children Eye Care Centre (DBCECC), L V Prasad Eye Institute (Kode Venkatadri Chowdary Campus), Vijayawada, Andhra Pradesh, India., Padhi TR; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Mithu Tulsi Chanrai Campus), Bhubaneswar, Odisha, India.; Miriam Hyman Children's Eye Care Centre (MHCECC), L V Prasad Eye Institute (MithuTulsi Chanrai Campus), Bhubaneswar, Odisha, India., Mettla AL; Allen Foster Community Eye Health Research Centre, Gullapalli Pratibha Rao International Centre for Advancement of Rural Eye care, L V Prasad Eye Institute, Hyderabad, Telangana, India.; School of Optometry and Vision Science, University of New South Wales, Sydney, Australia., Khanna RC; Allen Foster Community Eye Health Research Centre, Gullapalli Pratibha Rao International Centre for Advancement of Rural Eye care, L V Prasad Eye Institute, Hyderabad, Telangana, India. rohit@lvpei.org.; School of Optometry and Vision Science, University of New South Wales, Sydney, Australia. rohit@lvpei.org.; Brien Holden Eye Research Centre, L V Prasad Eye Institute, Banjara Hills, Hyderabad, Telangana, India. rohit@lvpei.org.; University of Rochester, School of Medicine and Dentistry, Rochester, NY, USA. rohit@lvpei.org.

Journal Article , 2024